对抗体与药物合物的暴露与不良事件关系的元分析
Cheng Wang1, Linda Irons2, Holly Kimko3
1Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, NY, USA.
Journal of clinical pharmacology
|November 14, 2024
概括
抗体与药物合物 (ADC) 毒性难以预测. 这项研究将特定的ADC有效载荷与不同的毒性驱动因素联系起来,有助于更安全的临床开发.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床毒理学 临床毒理学
背景情况:
- 抗体-药物联体 (ADC) 是关键的癌症治疗药物,但它们的毒性限制了临床成功.
- 鉴定ADC中的毒性驱动因素是复杂的,因为它们的复杂结构和药理动力学.
研究的目的:
- 量化关联临床不良事件 (AEs) 与ADC暴露参数.
- 为了确定与不同ADC类别中观察到的毒性相关的特定ADC分析物.
主要方法:
- 从六个ADC和三个有效载荷的40个出版物中分析临床暴露和安全数据.
- 使用逻辑模型,对9个暴露参数的不良事件 (AE) 的定量相关性.
主要成果:
- 德鲁克斯坦的ADC毒性与自由有效载荷暴露有很强的相关性.
- 单甲基奥里斯丁E (MMAE) ADC的毒性与曲线下的自由MMAE面积相关.
- 与剂量相关的Pyrrolobenzodiazepine ADC毒性,而不是特定的分析物.
结论:
- ADC毒性概况通常由使用相同细胞毒性有效载荷的ADC共享.
- 已识别的暴露-AE关系可以指导ADC开发的机制研究和剂量决定.
更多相关视频
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.7K
13:59High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
Published on: August 18, 2023
1.9K
相关概念视频
Pharmacovigilance
774
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
774
Allergic Drug Reactions
812
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
812
